Federated Hermes Inc. Purchases 13,497 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Federated Hermes Inc. raised its position in Pediatrix Medical Group, Inc. (NYSE:MD) by 5.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 283,793 shares of the company’s stock after buying an additional 13,497 shares during the quarter. Federated Hermes Inc. owned about 0.34% of Pediatrix Medical Group worth $2,639,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Pacer Advisors Inc. raised its stake in shares of Pediatrix Medical Group by 126.9% during the 4th quarter. Pacer Advisors Inc. now owns 3,235,729 shares of the company’s stock valued at $30,092,000 after purchasing an additional 1,809,828 shares during the period. Envestnet Asset Management Inc. raised its stake in shares of Pediatrix Medical Group by 250.6% during the 3rd quarter. Envestnet Asset Management Inc. now owns 267,434 shares of the company’s stock valued at $3,399,000 after purchasing an additional 191,154 shares during the period. Smith Graham & Co. Investment Advisors LP raised its stake in shares of Pediatrix Medical Group by 51.5% during the 4th quarter. Smith Graham & Co. Investment Advisors LP now owns 534,621 shares of the company’s stock valued at $4,972,000 after purchasing an additional 181,662 shares during the period. AQR Capital Management LLC raised its stake in shares of Pediatrix Medical Group by 43.7% during the 3rd quarter. AQR Capital Management LLC now owns 559,879 shares of the company’s stock valued at $7,116,000 after purchasing an additional 170,375 shares during the period. Finally, Trexquant Investment LP bought a new stake in shares of Pediatrix Medical Group during the 3rd quarter valued at $1,078,000. 97.71% of the stock is currently owned by institutional investors.

Pediatrix Medical Group Price Performance

MD opened at $9.04 on Friday. The stock has a 50-day moving average price of $9.20 and a 200-day moving average price of $9.61. Pediatrix Medical Group, Inc. has a 12-month low of $7.70 and a 12-month high of $15.06. The company has a current ratio of 1.24, a quick ratio of 1.24 and a debt-to-equity ratio of 0.73. The stock has a market capitalization of $759.63 million, a P/E ratio of -12.38, a PEG ratio of 2.40 and a beta of 1.58.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings data on Tuesday, February 20th. The company reported $0.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.30 by $0.02. Pediatrix Medical Group had a positive return on equity of 10.35% and a negative net margin of 3.03%. The firm had revenue of $496.44 million during the quarter, compared to analysts’ expectations of $524.30 million. During the same period in the prior year, the business earned $0.46 EPS. The company’s revenue for the quarter was down 3.4% compared to the same quarter last year. Equities analysts predict that Pediatrix Medical Group, Inc. will post 1.12 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on MD shares. Truist Financial reduced their target price on Pediatrix Medical Group from $10.50 to $10.00 and set a “hold” rating for the company in a research report on Wednesday, February 21st. Mizuho reduced their target price on Pediatrix Medical Group from $10.00 to $9.00 and set a “neutral” rating for the company in a research report on Wednesday, February 21st. TheStreet cut Pediatrix Medical Group from a “c” rating to a “d” rating in a research report on Friday, February 23rd. Finally, Jefferies Financial Group reduced their target price on Pediatrix Medical Group from $10.00 to $9.00 and set a “hold” rating for the company in a research report on Wednesday, March 6th. Five research analysts have rated the stock with a hold rating, According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $10.30.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.